SCHMC

Login 순천향대학교 부속 천안병원
검색

SCHMC Repository 진료부 종양혈액내과 1. Journal Papers

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)

Metadata Downloads
Abstract
We investigated the efficacy and safety of a trastuzumab biosimilar, Herzuma®, in combination with treatment of physician's choice (TPC) in patients with HER2+ metastatic breast cancer (MBC) who had failed at least two HER2 directed chemotherapies.
All Author(s)
S. H. Sim ; J. E. Kim ; M. H. Kim ; Y. H. Park ; J. H. Kim ; K. J. Suh ; S. J. Koh ; K. H. Park ; M. J. Kang ; M. S. Ahn ; K. E. Lee ; H. J. Kim ; H. K. Ahn ; K. U. Park ; J. H. Byun ; J. H. Park ; G. W. Lee ; K. S. Lee ; J. Sohn ; K. H. Jung ; I. H. Park
Issued Date
2022
Type
Article
Keyword
HER2 positive; Metastatic breast cancer; Trastuzumab biosimilar; Clinical trial; ctDNA
Publisher
Australasian Society for Breast Disease
European Society of Mastology
ISSN
0960-9776
Citation Title
The Breast
Citation Volume
65
Citation Start Page
172
Citation End Page
179
Language(ISO)
eng
DOI
10.1016/j.breast.2022.08.002
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/1701
Appears in Collections:
종양혈액내과 > 1. Journal Papers
공개 및 라이선스
  • 공개 구분공개
파일 목록

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

SCHMC Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.